首页> 外国专利> REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE FC.GAMMA.RI RECEPTOR

REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE FC.GAMMA.RI RECEPTOR

机译:通过连接巨噬细胞FC.GAMMA.RI受体逆转炎症反应

摘要

Ligation of the Fc.gamma. receptor type I (Fc.gamma.RI) on IL-10-producingcells leads to a selective upregulation of IL-10 production, which inturn induces a marked suppression of IL-12 biosynthesis by IL-12-producingcells, particularly macrophages. The ligation of the Fc.gamma.RIreceptor thus downmodulates IL-12 production via a mechanism that is dependenton macrophage-derived IL-10. Agents for ligating Fc.gamma.RIcomprise, for example, multivalent antibodies which bind the Fc.gamma.RIreceptor, immune complexes comprising antibodies which contain theFc region of IgG, and IgG multimers, preferably IgG dimers and trimers. Theligating agent may be administered to therapeutically inhibitproinflammatory immune responses. In particular, the ligating agent may beadministered to treat or prevent endotoxic shock associatedwith bacterial endotoxemia, and to treating autoimmune disorders.
机译:Fcγ的连接。产生IL-10的I型受体(FcγRI)细胞可导致IL-10产生选择性上调,诱导IL-12产生显着抑制IL-12生物合成细胞,特别是巨噬细胞。 FcγRI的连接受体因此通过一种依赖机制下调IL-12的产生在巨噬细胞来源的IL-10上。连接FcγRI的试剂包含例如结合FcγRI的多价抗体受体,包含抗体的免疫复合物,其中包含IgG的Fc区和IgG多聚体,优选IgG二聚体和三聚体。的可以施用结扎剂以治疗性抑制促炎性免疫反应。特别地,连接剂可以是用于治疗或预防内毒素休克细菌内毒素血症,并治疗自身免疫性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号